IIN

QTREX Quantum Ltd.

Stock
Stock
ISIN: IL0011715781
Ticker: IINN
IL0011715781
IINN

Price

Price

CHART BY

Frequently asked questions

The market capitalization of QTREX Quantum Ltd. is $125.43M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
QTREX Quantum Ltd.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.35. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover QTREX Quantum Ltd.'s stock, with a consensus target price of $5.00. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, QTREX Quantum Ltd. reported a revenue of $1.55M.
QTREX Quantum Ltd.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$12.93M. EBITDA measures the company's overall financial performance.
QTREX Quantum Ltd. has a free cash flow of -$8.75M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
QTREX Quantum Ltd. employs approximately 40 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of QTREX Quantum Ltd. is 58.55M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$125.43M
EPS (TTM) 
-$0.35
Free Float 
58.55M
Revenue (TTM) 
$1.55M
EBITDA (TTM) 
-$12.93M
Free Cashflow (TTM) 
-$8.75M

Pricing

52W span
$0.285$3.84

Analyst Ratings

The price target is $5.00 and the stock is covered by 1 analysts.

Buy

1

Hold

0

Sell

0

Information

QTREX Quantum Ltd. is a specialty medical device company, which engages in research, development, manufacturing, and marketing of proprietary life support technology with a vision to supersede traditional mechanical ventilators, or Mechanical Ventilation, which is the standard of care today for the treatment of acute respiratory failure. The company was founded by Dagi Shahar Ben Noon, Joe Hayon, and Udi Nussinovitch in July 2017 and is headquartered in Raanana, Israel.

Employees
40
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
IL0011715781
Primary Ticker
IINN
Fundamentals & EOD data from FactSet
Join the conversation